Novartis Pivotal Study of Exjade® Shows Significant Reduction of Iron Overload in Patients with Non-transfusion-dependent Thalassemia

Novartis Pivotal Study of Exjade® Shows Significant Reduction of Iron Overload in Patients with Non-transfusion-dependent Thalassemia

Dec 13, 2011
Source URL: https://qa1.novartis.us/news/media-releases/novartis-pivotal-study-exjade-shows-significant-reduction-iron-overload-patients-non-transfusion-dependent-thalassemia-0

List of links present in page
  1. https://qa1.novartis.us/news/media-releases/novartis-pivotal-study-exjade-shows-significant-reduction-iron-overload-patients-non-transfusion-dependent-thalassemia-0